PDPN and neoplasm: Here, patients with an expression of podoplanin in viable tumor cells (‘podoplanin positive’) showed a significantly better prognosis (Log-rank (Mantel-Cox) test; p = 0.0399, x2 = 4.223); the analysis of CAFs did not play a prognostic role in any of the subgroups put to test.